October 2019

ETAP-Lab will participate at MEDICA next 19 November in Dusseldorf. Our experts Dr. Jean-François BISSON (VP) and Dr. Nicolas Violle (CEO) will present ETAP-Lab’s services in the fields of preclinical Dermatology with our partner CYCERON. ETAP-Lab has a track-record of success in the testing of medical devices in the field of Dermatology, such as dressing, plaster and bandage. Please feel free to contact us if you want to schedule a one-to-one meeting. Looking forward to meeting with you. Contact us

ETAP-Lab will participate at Bio Europe next 11-13 November in Hamburg. Our experts Dr. Jean-François BISSON (VP) and Dr. Nicolas Violle (CEO) will present ETAP-Lab’s services in the fields of preclinical Dermatology and Central Nervous System. Please feel free to contact us if you want to schedule a one-to-one meeting. Looking forward to meeting with you.

Last June, we produced the 1st batch of beta-amyloid1-42 oligomers in our new facilities, using our unique know-how for oligomers production and stabilization (see here). We are very happy and proud to announce that we have now extensively validated the following in vitro pharmacological models: A model of Alzheimer’s disease: challenge with beta-Amyloid1-42 oligomers in rat primary cortical neuron culture; A model of Parkinson’s disease: challenge with alpha-synuclein oligomers in rat primary cortical neuron culture. Batch-to-batch oligomer production reproducibility has been controlled, confirming the